A proteome-wide CDK/CRK-specific kinase inhibitor promotes tumor cell death in the absence of cell cycle progression.
Caligiuri, Maureen
A proteome-wide CDK/CRK-specific kinase inhibitor promotes tumor cell death in the absence of cell cycle progression. [electronic resource] - Chemistry & biology Oct 2005 - 1103-15 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1074-5521
10.1016/j.chembiol.2005.08.008 doi
Antineoplastic Agents--pharmacology
Apoptosis--drug effects
Cell Cycle
Cell Line, Tumor
Cyclin-Dependent Kinases--antagonists & inhibitors
Drug Screening Assays, Antitumor
HCT116 Cells
Humans
Intracellular Signaling Peptides and Proteins--classification
Proteome--drug effects
Pyrimidines--classification
A proteome-wide CDK/CRK-specific kinase inhibitor promotes tumor cell death in the absence of cell cycle progression. [electronic resource] - Chemistry & biology Oct 2005 - 1103-15 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1074-5521
10.1016/j.chembiol.2005.08.008 doi
Antineoplastic Agents--pharmacology
Apoptosis--drug effects
Cell Cycle
Cell Line, Tumor
Cyclin-Dependent Kinases--antagonists & inhibitors
Drug Screening Assays, Antitumor
HCT116 Cells
Humans
Intracellular Signaling Peptides and Proteins--classification
Proteome--drug effects
Pyrimidines--classification